We then assessed the associations of age at diagnosis, MYCN amplification, TP53, CCNE1, CDK2, CHEK2 and SESN1 in the prediction of the overall survival of neuroblastoma using a multivariate Cox regression assay. This evidence concerns the gene CHEK2 and neuroblastoma.